<![CDATA[Press Releases - Radius Health, Inc]]> <![CDATA[Radius Health Completes $43 Million Financing to Advance BA058 for the Treatment of Osteoporosis ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-completes-43-million-financing-to-a-1010547?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-completes-43-million-financing-to-a-1010547?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 25 Apr 2013 12:00:00 GMT <![CDATA[Radius Health to Present at BIO Business Forum(R) ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-to-present-at-bio-business-forumr-1008661?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-to-present-at-bio-business-forumr-1008661?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 18 Apr 2013 15:30:00 GMT <![CDATA[Radius Health Completes Enrollment for Phase 3 Study of Bone-Building Osteoporosis Drug ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-completes-enrollment-for-phase-3-stu-995700?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-completes-enrollment-for-phase-3-stu-995700?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 12 Mar 2013 13:38:00 GMT <![CDATA[Radius Health to Present at Cowen & Company 33rd Annual Health Care Conference in Boston ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-to-present-at-cowen-company-33rd-a-990467?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-to-present-at-cowen-company-33rd-a-990467?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 26 Feb 2013 17:40:49 GMT <![CDATA[Radius Health to Present at BIO CEO & Investor in New York ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-to-present-at-bio-ceo-investor-in--983687?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-to-present-at-bio-ceo-investor-in--983687?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 08 Feb 2013 17:37:43 GMT <![CDATA[Radius Provides Update on Pivotal Phase 3 Program for BA058-SC Injection ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-provides-update-on-pivotal-phase-3-program--971511?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-provides-update-on-pivotal-phase-3-program--971511?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 07 Jan 2013 16:15:00 GMT <![CDATA[Radius Completes Enrollment for Phase 2 Study of BA058-Transdermal Patch for Treatment of Postmenopausal Osteoporosis ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-completes-enrollment-for-phase-2-study-of-b-970749?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-completes-enrollment-for-phase-2-study-of-b-970749?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 03 Jan 2013 20:30:00 GMT <![CDATA[Radius, 3M drug delivery systems announce exclusive agreement for development, commercialization of transdermal delivery of BA058 for Osteoporosis ]]> http://radiuspharm.mwnewsroom.com/manual-releases/Radius,-3M-drug-delivery-systems-announce-exclusiv?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Radius,-3M-drug-delivery-systems-announce-exclusiv?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 20 Dec 2012 21:56:53 GMT <![CDATA[Radius Health Withdraws Registration Statement ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-withdraws-registration-statement-0955224?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-withdraws-registration-statement-0955224?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 15 Nov 2012 22:33:19 GMT <![CDATA[Radius Health Announces Upcoming Scientific Presentations at the American Society for Bone and Mineral Research 2012 Annual Meeting ]]> http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Health-Announces-Upcoming-Scientific-Presen?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Health-Announces-Upcoming-Scientific-Presen?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 12 Oct 2012 18:57:00 GMT <![CDATA[Radius Initiates Phase 2 Study of BA058-Transdermal for the Treatment of Postmenopausal Osteoporosis]]> http://radiuspharm.mwnewsroom.com/manual-releases/RADIUS-INITIATES-PHASE-2-STUDY-OF-BA058-TRANSDERMA?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/RADIUS-INITIATES-PHASE-2-STUDY-OF-BA058-TRANSDERMA?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 27 Sep 2012 12:00:00 GMT <![CDATA[Radius Health Announces Upcoming Scientific Presentations at ENDO 2012, the Endocrine Society's 94th Annual Meeting ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-announces-upcoming-scientific-presen-0902413?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-announces-upcoming-scientific-presen-0902413?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 22 Jun 2012 16:18:18 GMT <![CDATA[Radius Announces Appointment of Michael Franken as Senior Vice President and Chief Business Officer]]> http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Announces-Appointment-of-Michael-Franken-as?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Announces-Appointment-of-Michael-Franken-as?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 20 Apr 2012 04:00:00 GMT <![CDATA[Radius Health, Inc. Files Registration Statement for Proposed Public Offering ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-health-inc-files-registration-statement-f-0848902?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-health-inc-files-registration-statement-f-0848902?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 07 Feb 2012 11:00:00 GMT <![CDATA[Radius Announces Topline Results of Successful Phase 1b Clinical Trial of BA058 Microneedle Patch for the Transdermal Treatment of Osteoporosis]]> http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Announces-Topline-Results-of-Successful-Pha?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Announces-Topline-Results-of-Successful-Pha?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Wed, 21 Dec 2011 12:00:00 GMT <![CDATA[Radius Closes $21.4 Million Third and Final Equity Tranche of Previously Announced Financing ]]> http://radiuspharm.mwnewsroom.com/press-releases/radius-closes-21-4-million-third-and-final-equity-0833610?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/press-releases/radius-closes-21-4-million-third-and-final-equity-0833610?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 16 Dec 2011 12:16:40 GMT <![CDATA[Radius Transitions Company Leadership; Names Michael Wyzga President and Chief Executive Officer to Advance Phase 3 Osteoporosis Drug and Drive Corporate Strategy ]]> http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Transitions-Company-Leadership;-Names-Micha?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Radius-Transitions-Company-Leadership;-Names-Micha?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 05 Dec 2011 12:00:00 GMT <![CDATA[Radius Closes $27.65 Million Second Tranche of Previously Announced Financing]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Closes-$27-65-Million-Second-Tranche-of-Pre?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Closes-$27-65-Million-Second-Tranche-of-Pre?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Wed, 23 Nov 2011 14:57:26 GMT <![CDATA[Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Closing-of-$91-Million-Financing-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Closing-of-$91-Million-Financing-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 24 May 2011 04:00:01 GMT <![CDATA[Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius,-3M-Drug-Delivery-Systems-Sign-Development-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius,-3M-Drug-Delivery-Systems-Sign-Development-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 24 May 2011 04:00:00 GMT <![CDATA[Radius Presents Positive Phase 2a Study Results Establishing Clinical Proof of Concept for RAD1901 in Reducing Menopausal Hot Flashes]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Presents-Positive-Phase-2a-Study-Results-Es?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Presents-Positive-Phase-2a-Study-Results-Es?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Sat, 19 Jun 2010 04:00:00 GMT <![CDATA[Radius’ Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius’-Investigational-Bone-Anabolic-Agent,-BA058?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius’-Investigational-Bone-Anabolic-Agent,-BA058?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Wed, 05 Aug 2009 04:00:00 GMT <![CDATA[Radius Initiates Phase 2a Clinical Trial of RAD1901 in Menopausal Hot Flashes]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Initiates-Phase-2a-Clinical-Trial-of-RAD190?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Initiates-Phase-2a-Clinical-Trial-of-RAD190?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 24 Mar 2009 04:00:00 GMT <![CDATA[Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Raises-Additional-$15-Million,-Increasing-S?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Raises-Additional-$15-Million,-Increasing-S?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 20 Nov 2008 05:00:00 GMT <![CDATA[Radius Selects First Preclinical Candidate from SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Selects-First-Preclinical-Candidate-from-SA?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Selects-First-Preclinical-Candidate-from-SA?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 09 Jun 2008 04:00:00 GMT <![CDATA[Radius Completes Enrollment of Phase 2 Clinical Trial of BA058 for Osteoporosis]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Completes-Enrollment-of-Phase-2-Clinical-Tr?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Completes-Enrollment-of-Phase-2-Clinical-Tr?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Wed, 02 Apr 2008 04:00:00 GMT <![CDATA[Radius Announces Launch of RAD1901 Clinical Program for the Treatment of Hot Flashes]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Launch-of-RAD1901-Clinical-Progra?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Launch-of-RAD1901-Clinical-Progra?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Wed, 30 Jan 2008 05:00:00 GMT <![CDATA[Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis / MPM Bio IV NVS Strategic Fund L.P. invests $10 million in Radius]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Grants-Major-Pharmaceutical-Company-Exclusi?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Grants-Major-Pharmaceutical-Company-Exclusi?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 17 Sep 2007 04:00:00 GMT <![CDATA[Radius Presents Positive Results from Phase 1B Clinical Trial of BA058 and Preclinical Study of RAD1901 at ENDO 2007]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Presents-Positive-Results-from-Phase-1B-Cli?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Presents-Positive-Results-from-Phase-1B-Cli?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 08 Jun 2007 11:00:00 GMT <![CDATA[Radius Raises $57.5 Million in Second Private Financing Round]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Raises-$57-5-Million-in-Second-Private-Fina?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Raises-$57-5-Million-in-Second-Private-Fina?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 02 Apr 2007 11:00:00 GMT <![CDATA[Radius Begins Phase 2 Clinical Trial of BA058 for Osteoporosis]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Begins-Phase-2-Clinical-Trial-of-BA058-for-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Begins-Phase-2-Clinical-Trial-of-BA058-for-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 20 Mar 2007 04:00:00 GMT <![CDATA[Radius Appoints Nick Harvey Senior Vice President and CFO]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Appoints-Nick-Harvey-Senior-Vice-President-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Appoints-Nick-Harvey-Senior-Vice-President-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 02 Jan 2007 12:00:00 GMT <![CDATA[Radius Licenses Worldwide Exclusive Rights to Estrogen Receptor-Beta Agonists]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Licenses-Worldwide-Exclusive-Rights-to-Estr?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Licenses-Worldwide-Exclusive-Rights-to-Estr?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 07 Aug 2006 11:00:00 GMT <![CDATA[Radius Announces Licensing Agreement to Develop and Commercialize Eisai SERMs]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Licensing-Agreement-to-Develop-an?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Licensing-Agreement-to-Develop-an?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Thu, 29 Jun 2006 04:00:00 GMT <![CDATA[Radius Appoints Louis O’Dea Senior Vice President and Chief Medical Officer]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Appoints-Louis-O’Dea-Senior-Vice-President-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Appoints-Louis-O’Dea-Senior-Vice-President-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Wed, 12 Apr 2006 04:00:00 GMT <![CDATA[Radius Announces Licensing Agreement for Ipsen Osteoporosis Proprietary Molecule BA058 / PTHrP Analog in Phase 1 Clinical Trials]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Licensing-Agreement-for-Ipsen-Ost?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Radius-Announces-Licensing-Agreement-for-Ipsen-Ost?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Tue, 13 Dec 2005 12:00:00 GMT <![CDATA[Nuvios* Names Dr. Christopher Glass to Scientific Advisory Board]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Nuvios--Names-Dr--Christopher-Glass-to-Scientific-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Nuvios--Names-Dr--Christopher-Glass-to-Scientific-?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Fri, 12 Nov 2004 12:00:00 GMT <![CDATA[Nuvios* Names C. Richard Lyttle President and CEO]]> http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Nuvios--Names-C--Richard-Lyttle-President-and-CEO?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 http://radiuspharm.mwnewsroom.com/manual-releases/Archive/Nuvios--Names-C--Richard-Lyttle-President-and-CEO?feed=429e0be3-9aef-4a3a-9775-43f8e470d510 Mon, 04 Oct 2004 11:00:00 GMT